SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'EDJ'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MUO_A_ADNA1_1 (AURORA-RELATED KINASE 1)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 9	LEU A 22 GLY A 23 VAL A 30 ALA A 43 TYR A 95 LEU A 146	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.8A) EDJ A 301 ( 4.5A)	0.67A	1muoA-6bx6A: 20.7	1muoA-6bx6A: 15.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	7 / 12	LEU A 22 GLY A 23 VAL A 30 ALA A 43 MET A 93 TYR A 95 VAL A 96	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.2A) EDJ A 301 ( 4.8A) EDJ A 301 (-3.7A)	0.66A	2fumB-6bx6A: 22.4	2fumB-6bx6A: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 12	LEU A 22 ALA A 43 MET A 93 TYR A 95 VAL A 96 ASN A 144	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) EDJ A 301 ( 4.2A) EDJ A 301 ( 4.8A) EDJ A 301 (-3.7A) None	0.78A	2fumC-6bx6A: 22.4	2fumC-6bx6A: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 12	LEU A 22 GLY A 23 VAL A 30 ALA A 43 TYR A 95 VAL A 96	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.8A) EDJ A 301 (-3.7A)	0.63A	2fumC-6bx6A: 22.4	2fumC-6bx6A: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 12	LEU A 22 VAL A 30 ALA A 43 MET A 93 TYR A 95 VAL A 96	EDJ A 301 (-3.9A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.2A) EDJ A 301 ( 4.8A) EDJ A 301 (-3.7A)	0.71A	2fumC-6bx6A: 22.4	2fumC-6bx6A: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FUP_A_MI1A1_1 (TYROSINE-PROTEIN KINASE JAK2)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	8 / 12	LEU A 22 GLY A 23 GLY A 25 GLY A 28 VAL A 30 ALA A 43 MET A 93 TYR A 95	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) None None None EDJ A 301 (-3.4A) EDJ A 301 ( 4.2A) EDJ A 301 ( 4.8A)	0.64A	3fupA-6bx6A: 18.4	3fupA-6bx6A: 14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0F_A_B49A9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 11	LEU A 22 VAL A 30 ALA A 43 TYR A 95 GLY A 99 LEU A 146	EDJ A 301 (-3.9A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.8A) EDJ A 301 ( 3.7A) EDJ A 301 ( 4.5A)	0.53A	3g0fA-6bx6A: 18.8	3g0fA-6bx6A: 14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXN_A_MI1A1_1 (NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	7 / 12	LEU A 22 GLY A 23 GLY A 25 ALA A 43 ILE A 77 TYR A 95 VAL A 96	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.7A) EDJ A 301 ( 4.8A) EDJ A 301 (-3.7A)	0.63A	3lxnA-6bx6A: 18.9	3lxnA-6bx6A: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXN_A_MI1A1_1 (NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	7 / 12	LEU A 22 GLY A 23 GLY A 25 VAL A 30 ALA A 43 ILE A 77 TYR A 95	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) None None EDJ A 301 (-3.4A) EDJ A 301 ( 4.7A) EDJ A 301 ( 4.8A)	0.61A	3lxnA-6bx6A: 18.9	3lxnA-6bx6A: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	5 / 9	ILE A 76 ILE A 77 MET A 91 TYR A 95 ILE A 155	None EDJ A 301 ( 4.7A) None EDJ A 301 ( 4.8A) None	0.52A	3zosA-6bx6A: 18.8	3zosA-6bx6A: 16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	5 / 9	LEU A 22 ILE A 76 MET A 91 TYR A 95 ILE A 155	EDJ A 301 (-3.9A) None None EDJ A 301 ( 4.8A) None	0.45A	3zosB-6bx6A: 18.8	3zosB-6bx6A: 16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	7 / 12	VAL A 30 ALA A 43 ILE A 77 MET A 91 TYR A 95 LEU A 146 ALA A 156	None EDJ A 301 (-3.4A) EDJ A 301 ( 4.7A) None EDJ A 301 ( 4.8A) EDJ A 301 ( 4.5A) EDJ A 301 (-3.2A)	1.12A	4bkjA-6bx6A: 18.7	4bkjA-6bx6A: 16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 12	VAL A 30 ALA A 43 ILE A 77 MET A 91 LEU A 146 ALA A 156	None EDJ A 301 (-3.4A) EDJ A 301 ( 4.7A) None EDJ A 301 ( 4.5A) EDJ A 301 (-3.2A)	1.07A	4bkjB-6bx6A: 18.6	4bkjB-6bx6A: 16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	4 / 5	VAL A 30 ILE A 76 TYR A 95 ILE A 155	None None EDJ A 301 ( 4.8A) None	0.71A	4c8bA-6bx6A: 19.9	4c8bA-6bx6A: 13.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 12	GLY A 23 VAL A 30 ALA A 43 MET A 93 TYR A 95 LEU A 146	EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.2A) EDJ A 301 ( 4.8A) EDJ A 301 ( 4.5A)	0.74A	4qmzA-6bx6A: 14.1	4qmzA-6bx6A: 13.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TYJ_A_0LIA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	4 / 6	LEU A 22 VAL A 30 ILE A 76 ILE A 155	EDJ A 301 (-3.9A) None None None	0.72A	4tyjA-6bx6A: 19.2	4tyjA-6bx6A: 13.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 10	LEU A 22 VAL A 30 ILE A 77 TYR A 95 LEU A 146 ILE A 155	EDJ A 301 (-3.9A) None EDJ A 301 ( 4.7A) EDJ A 301 ( 4.8A) EDJ A 301 ( 4.5A) None	0.73A	4v04B-6bx6A: 19.4	4v04B-6bx6A: 14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WBO_C_ANWC601_0 (RHODOPSIN KINASE)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	4 / 6	LEU A 22 ALA A 43 MET A 93 LEU A 146	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) EDJ A 301 ( 4.2A) EDJ A 301 ( 4.5A)	0.71A	4wboC-6bx6A: 21.2	4wboC-6bx6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	5 / 9	GLY A 23 VAL A 30 ALA A 43 ILE A 77 MET A 93	EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.7A) EDJ A 301 ( 4.2A)	0.72A	5lw1B-6bx6A: 14.3	5lw1B-6bx6A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	5 / 10	GLY A 23 VAL A 30 ALA A 43 ILE A 77 MET A 93	EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.7A) EDJ A 301 ( 4.2A)	0.77A	5lw1E-6bx6A: 16.4	5lw1E-6bx6A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N3H_A_NCAA401_0 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 10	LEU A 22 VAL A 30 ALA A 43 MET A 93 TYR A 95 VAL A 96	EDJ A 301 (-3.9A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.2A) EDJ A 301 ( 4.8A) EDJ A 301 (-3.7A)	0.46A	5n3hA-6bx6A: 23.8	5n3hA-6bx6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N3H_A_NCAA401_0 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	6 / 10	LEU A 22 VAL A 30 ALA A 43 TYR A 95 VAL A 96 LEU A 146	EDJ A 301 (-3.9A) None EDJ A 301 (-3.4A) EDJ A 301 ( 4.8A) EDJ A 301 (-3.7A) EDJ A 301 ( 4.5A)	0.68A	5n3hA-6bx6A: 23.8	5n3hA-6bx6A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XV7_A_EMHA705_1 (SERINE-ARGININE (SR) PROTEIN KINASE 1)	6bx6	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (Homo sapiens)	5 / 12	LEU A 22 GLY A 23 VAL A 30 ALA A 43 ALA A 156	EDJ A 301 (-3.9A) EDJ A 301 (-3.4A) None EDJ A 301 (-3.4A) EDJ A 301 (-3.2A)	0.55A	5xv7A-6bx6A: 18.6	5xv7A-6bx6A: 26.67

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MUO_A_ADNA1_1","AURORA-RELATED KINASE 1","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;GLY A  23;VAL A  30;ALA A  43;TYR A  95;LEU A 146","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.8A);EDJ A 301 ( 4.5A)","0.67A","1muoA-6bx6A:20.7",null],["2FUM_B_MIXB1539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",7,"LEU A  22;GLY A  23;VAL A  30;ALA A  43;MET A  93;TYR A  95;VAL A  96","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.2A);EDJ A 301 ( 4.8A);EDJ A 301 (-3.7A)","0.66A","2fumB-6bx6A:22.4","1muoA-6bx6A:15.52"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;ALA A  43;MET A  93;TYR A  95;VAL A  96;ASN A 144","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);EDJ A 301 ( 4.2A);EDJ A 301 ( 4.8A);EDJ A 301 (-3.7A);None","0.78A","2fumC-6bx6A:22.4","2fumB-6bx6A:13.04"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;GLY A  23;VAL A  30;ALA A  43;TYR A  95;VAL A  96","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.8A);EDJ A 301 (-3.7A)","0.63A","2fumC-6bx6A:22.4","2fumC-6bx6A:13.04"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;VAL A  30;ALA A  43;MET A  93;TYR A  95;VAL A  96","EDJ A 301 (-3.9A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.2A);EDJ A 301 ( 4.8A);EDJ A 301 (-3.7A)","0.71A","2fumC-6bx6A:22.4","2fumC-6bx6A:13.04"],["3FUP_A_MI1A1_1","TYROSINE-PROTEIN KINASE JAK2","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",8,"LEU A  22;GLY A  23;GLY A  25;GLY A  28;VAL A  30;ALA A  43;MET A  93;TYR A  95","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);None;None;None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.2A);EDJ A 301 ( 4.8A)","0.64A","3fupA-6bx6A:18.4","2fumC-6bx6A:13.04"],["3G0F_A_B49A9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;VAL A  30;ALA A  43;TYR A  95;GLY A  99;LEU A 146","EDJ A 301 (-3.9A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.8A);EDJ A 301 ( 3.7A);EDJ A 301 ( 4.5A)","0.53A","3g0fA-6bx6A:18.8","3fupA-6bx6A:14.63"],["3LXN_A_MI1A1_1","NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",7,"LEU A  22;GLY A  23;GLY A  25;ALA A  43;ILE A  77;TYR A  95;VAL A  96","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.7A);EDJ A 301 ( 4.8A);EDJ A 301 (-3.7A)","0.63A","3lxnA-6bx6A:18.9","3g0fA-6bx6A:14.84"],["3LXN_A_MI1A1_1","NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",7,"LEU A  22;GLY A  23;GLY A  25;VAL A  30;ALA A  43;ILE A  77;TYR A  95","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);None;None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.7A);EDJ A 301 ( 4.8A)","0.61A","3lxnA-6bx6A:18.9","3lxnA-6bx6A:14.29"],["3ZOS_A_0LIA1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",5,"ILE A  76;ILE A  77;MET A  91;TYR A  95;ILE A 155","None;EDJ A 301 ( 4.7A);None;EDJ A 301 ( 4.8A);None","0.52A","3zosA-6bx6A:18.8","3lxnA-6bx6A:14.29"],["3ZOS_B_0LIB1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",5,"LEU A  22;ILE A  76;MET A  91;TYR A  95;ILE A 155","EDJ A 301 (-3.9A);None;None;EDJ A 301 ( 4.8A);None","0.45A","3zosB-6bx6A:18.8","3zosA-6bx6A:16.22"],["4BKJ_A_STIA1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",7,"VAL A  30;ALA A  43;ILE A  77;MET A  91;TYR A  95;LEU A 146;ALA A 156","None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.7A);None;EDJ A 301 ( 4.8A);EDJ A 301 ( 4.5A);EDJ A 301 (-3.2A)","1.12A","4bkjA-6bx6A:18.7","3zosB-6bx6A:16.22"],["4BKJ_B_STIB1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"VAL A  30;ALA A  43;ILE A  77;MET A  91;LEU A 146;ALA A 156","None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.7A);None;EDJ A 301 ( 4.5A);EDJ A 301 (-3.2A)","1.07A","4bkjB-6bx6A:18.6","4bkjA-6bx6A:16.22"],["4C8B_A_0LIA1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",4,"VAL A  30;ILE A  76;TYR A  95;ILE A 155","None;None;EDJ A 301 ( 4.8A);None","0.71A","4c8bA-6bx6A:19.9","4bkjB-6bx6A:16.22"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"GLY A  23;VAL A  30;ALA A  43;MET A  93;TYR A  95;LEU A 146","EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.2A);EDJ A 301 ( 4.8A);EDJ A 301 ( 4.5A)","0.74A","4qmzA-6bx6A:14.1","4c8bA-6bx6A:13.31"],["4TYJ_A_0LIA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",4,"LEU A  22;VAL A  30;ILE A  76;ILE A 155","EDJ A 301 (-3.9A);None;None;None","0.72A","4tyjA-6bx6A:19.2","4qmzA-6bx6A:13.90"],["4V04_B_0LIB1771_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;VAL A  30;ILE A  77;TYR A  95;LEU A 146;ILE A 155","EDJ A 301 (-3.9A);None;EDJ A 301 ( 4.7A);EDJ A 301 ( 4.8A);EDJ A 301 ( 4.5A);None","0.73A","4v04B-6bx6A:19.4","4tyjA-6bx6A:13.77"],["4WBO_C_ANWC601_0","RHODOPSIN KINASE","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",4,"LEU A  22;ALA A  43;MET A  93;LEU A 146","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);EDJ A 301 ( 4.2A);EDJ A 301 ( 4.5A)","0.71A","4wboC-6bx6A:21.2","4v04B-6bx6A:14.95"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",5,"GLY A  23;VAL A  30;ALA A  43;ILE A  77;MET A  93","EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.7A);EDJ A 301 ( 4.2A)","0.72A","5lw1B-6bx6A:14.3","4wboC-6bx6A:undetectable"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",5,"GLY A  23;VAL A  30;ALA A  43;ILE A  77;MET A  93","EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.7A);EDJ A 301 ( 4.2A)","0.77A","5lw1E-6bx6A:16.4","5lw1B-6bx6A:20.24"],["5N3H_A_NCAA401_0","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;VAL A  30;ALA A  43;MET A  93;TYR A  95;VAL A  96","EDJ A 301 (-3.9A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.2A);EDJ A 301 ( 4.8A);EDJ A 301 (-3.7A)","0.46A","5n3hA-6bx6A:23.8","5lw1E-6bx6A:20.24"],["5N3H_A_NCAA401_0","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",6,"LEU A  22;VAL A  30;ALA A  43;TYR A  95;VAL A  96;LEU A 146","EDJ A 301 (-3.9A);None;EDJ A 301 (-3.4A);EDJ A 301 ( 4.8A);EDJ A 301 (-3.7A);EDJ A 301 ( 4.5A)","0.68A","5n3hA-6bx6A:23.8","5n3hA-6bx6A:undetectable"],["5XV7_A_EMHA705_1","SERINE-ARGININE (SR) PROTEIN KINASE 1","6bx6","5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2","Homo sapiens",5,"LEU A  22;GLY A  23;VAL A  30;ALA A  43;ALA A 156","EDJ A 301 (-3.9A);EDJ A 301 (-3.4A);None;EDJ A 301 (-3.4A);EDJ A 301 (-3.2A)","0.55A","5xv7A-6bx6A:18.6","5n3hA-6bx6A:undetectable"]]